EXFORGE HCT

This brand name is authorized in Austria, Australia, Brazil, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Lithuania, Mexico, Nigeria, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, United States

Active ingredients

The drug EXFORGE HCT contains a combination of these active pharmaceutical ingredients (APIs):

1 Amlodipine UNII 864V2Q084H - AMLODIPINE BESYLATE

Amlodipine is a calcium ion influx inhibitor of the dihydropyridine group (slow channel blocker or calcium ion antagonist) and inhibits the transmembrane influx of calcium ions into cardiac and vascular smooth muscle. Read about Amlodipine

2 Valsartan UNII 80M03YXJ7I - VALSARTAN

Valsartan is an orally active, potent, and specific angiotensin II (Ang II) receptor antagonist. It acts selectively on the AT1-receptor subtype, which is responsible for the known actions of angiotensin II. Read about Valsartan

3 Hydrochlorothiazide UNII 0J48LPH2TH - HYDROCHLOROTHIAZIDE

Hydrochlorothiazide is a diuretic with antihypertensive properties. It acts by inhibiting the renal tubular re-absorption of sodium and chloride ions, which are excreted with an accompanying volume of water. Potassium excretion is also promoted. Read about Hydrochlorothiazide

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C09DX01	Valsartan, amlodipine and hydrochlorothiazide	C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09D Angiotensin II antagonists, combinations → C09DX Angiotensin II antagonists, other combinations
Discover more medicines within C09DX01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 5285E, 5286F, 5287G, 5288H, 5289J
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 526513030076804, 526513030077004, 526513030077104, 526513030077204, 526513030077404, 526513030077604, 526513030077704
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 1650-MEE-0116, 241-MEE-0414, 279-MEE-0514, 411-MEE-0814, 524-MEE-1114
Country: EE	Ravimiamet	Identifier(s): 1440122, 1440133, 1440144, 1440155, 1440166, 1440177, 1440188, 1440199, 1440201, 1440212, 1440223, 1440234, 1440245, 1440256, 1440267, 1440278, 1440289, 1440290, 1440302, 1440313, 1440324, 1440335, 1440346, 1440357, 1440368, 1440379, 1440380, 1440391, 1440403, 1440414, 1440425, 1440436, 1440447, 1440458, 1440469
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 09569002, 09569014, 09569026, 09569038, 109569050
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 055620, 055631, 055643, 055654, 055711, 055722
Country: FR	Base de données publique des médicaments	Identifier(s): 61045063, 63945271, 64617605, 65369123
Country: HK	Department of Health Drug Office	Identifier(s): 60136, 60137, 60138, 60139, 60140, 62221, 62222, 62223
Country: IE	Health Products Regulatory Authority	Identifier(s): 14359, 14463, 14572, 14578, 14579, 32667, 32668
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1051257, 1051258, 1051259, 1051260, 1051261, 1051262, 1051263, 1051264, 1051266, 1051267, 1051268, 1051269, 1051270, 1051271, 1051272, 1051273, 1051274, 1051275, 1051276, 1051277, 1051278, 1051279, 1051280, 1051281, 1051282, 1051283, 1051284, 1051285, 1051286, 1051287, 1051288, 1051289, 1051290, 1051291, 1051292, 1051293, 1051294, 1051295, 1051296, 1051297, 1051298, 1051299, 1051300, 1051301, 1051302, 1051303, 1051304, 1051305, 1051306, 1051307, 1051308, 1051309, 1051310, 1051311, 1051312, 1051313, 1051314, 1051315, 1051316, 1051317
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 200M2009
Country: NG	Registered Drug Product Database	Identifier(s): A4-5824, A4-5825, A4-5827, B4-1427
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 123420, 123439, 123447, 123455, 123463
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 14529, 14530, 14531, 14532, 14533
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100094647, 100095150, 100101301, 100215750, 100224676
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W64768001, W64768002, W64768003, W64768004, W64768005, W64768006, W64768007, W64768008, W64768009, W64768010, W64768011, W64768012, W64769001, W64769002, W64769003, W64769004, W64769005, W64769006, W64769007, W64769008, W64769009, W64769010, W64769011, W64769012, W64770001, W64770002, W64770003, W64770004, W64770005, W64770006, W64770007, W64770008, W64770009, W64770010, W64770011, W64770012, W64771001, W64771002, W64771003, W64771004, W64771005, W64771006, W64771007, W64771008, W64771009, W64771010, W64771011, W64771012, W68729001, W68729002, W68729003, W68729004, W68729005, W68729006, W68729007, W68729008, W68729009, W68729010, W68729011, W68729012
Country: SG	Health Sciences Authority	Identifier(s): 13898P, 13899P, 13900P, 13901P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 10283205, 10283206, 10283207, 10283208
Country: US	FDA, National Drug Code	Identifier(s): 0078-0559, 0078-0560, 0078-0561, 0078-0562, 0078-0563